Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.
Uterine leiomyosarcoma is an aggressive tumor typically found at advanced stages due to difficulties with early diagnosis. Because uterine leiomyosarcoma is resistant to conventional radiation and chemotherapy, the development of more potent medical therapeutics is anticipated. Using quantitative re...
Main Authors: | Kenichi Makino, Kazuhiro Kawamura, Wataru Sato, Nanami Kawamura, Toshio Fujimoto, Yukihiro Terada |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3402458?pdf=render |
Similar Items
-
Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
by: Åman Pierre, et al.
Published: (2008-01-01) -
Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
by: Yuko Ariza, et al.
Published: (2019-06-01) -
The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
by: Philipp Berning, et al.
Published: (2020-04-01) -
Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas <it>in vitro </it>and <it>in vivo</it>
by: Petru Edgar, et al.
Published: (2010-03-01) -
High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition
by: Miriam Sartages, et al.
Published: (2020-12-01)